Auditory sensory memory and the cholinergic system:: Implications for Alzheimer's disease

被引:74
|
作者
Pekkonen, E [1 ]
Hirvonen, J
Jääskeläinen, IP
Kaakkola, S
Huttunen, J
机构
[1] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland
[2] Univ Helsinki, Dept Psychol, Cognit Brain Res Unit, SF-00100 Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, BioMag Lab, Med Engn Ctr, Helsinki, Finland
[4] Univ Helsinki, Cent Hosp, Dept Clin Neurophysiol, Helsinki, Finland
基金
芬兰科学院;
关键词
D O I
10.1006/nimg.2001.0805
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Auditory sensory memory represents one of the simplest types of short-term memory that can be studied electrophysiologically with mismatch negativity (MMN); a specific auditory event-related potential indexing automatic comparison of incoming stimuli to an existing memory trace. Previous results suggest that auditory sensory memory deteriorates in aging and especially Mi Alzheimer's disease (AD). It has remained unsettled, however, whether MMN is regulated by the cholinergic system, which is deteriorated in AD contributing to cognitive impairments. We recorded cortical auditory responses with a magnetometer from 13 healthy subjects after intravenous injection of scopolamine, centrally acting cholinergic antagonist, or glycopyrrolate, a drug with a peripheral anticholinergic properties without penetrating the blood-brain barrier, using a double-blind protocol. Scopolamine reduced MMNm amplitude in response to frequency, but not duration, change, increased P50m amplitude, and delayed N100m latency. These findings suggest that the cholinergic system regulates the frequency-specific comparison of incoming stimuli to existing memory trace and modulates the preattentive processing related to stimulus detection. Further, neural mechanisms responsible for cortical frequency- and duration-specific discrimination appear to have different sensitivities to cholinergic modulation. Auditory evoked potentials might be suitable to monitor cholinergic activity in AD. (C) 2001 Academic Press.
引用
收藏
页码:376 / 382
页数:7
相关论文
共 50 条
  • [11] The cerebrovascular role of the cholinergic neural system in Alzheimer's disease
    Van Beek, Arenda H. E. A.
    Claassen, Jurgen A. H. R.
    BEHAVIOURAL BRAIN RESEARCH, 2011, 221 (02) : 537 - 542
  • [12] Cognitive ageing and Alzheimer's disease: the cholinergic system redux
    Sultzer, David L.
    BRAIN, 2018, 141 : 626 - 628
  • [13] THE CHOLINERGIC SYSTEM IN ALZHEIMER-DISEASE
    GIACOBINI, E
    PROGRESS IN BRAIN RESEARCH, 1990, 84 : 321 - 332
  • [14] Cholinergic agonists modify attentional, not memory systems in Alzheimer's disease(AD).
    Chertkow, H
    Murtha, S
    Bergman, H
    Bergman, S
    Lubarsky, S
    JOURNAL OF COGNITIVE NEUROSCIENCE, 1999, : 67 - 67
  • [15] The cholinergic deficit in Alzheimer's disease
    Davies, Peter
    Alzheimer: 100 Years and Beyond, 2006, : 123 - 125
  • [16] Cholinergic function and Alzheimer's disease
    Giacobini, E
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 : S1 - S5
  • [17] Interactions between β-amyloid and central cholinergic neurons:: implications for Alzheimer's disease
    Kar, S
    Slowikowski, SPM
    Westaway, D
    Mount, HTJ
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2004, 29 (06): : 427 - 441
  • [18] The cholinergic deficit in Alzheimer's disease
    Whitehouse, PJ
    JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 : 19 - 22
  • [19] Cholinergic strategies for Alzheimer’s disease
    J. Winkler
    Leon J. Thal
    Fred H. Gage
    Lisa J. Fisher
    Journal of Molecular Medicine, 1998, 76 : 555 - 567
  • [20] Cholinergic strategies for Alzheimer's disease
    Winkler, J
    Thal, LJ
    Gage, FH
    Fisher, LJ
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1998, 76 (08): : 555 - 567